申请人:BRISTOL MYERS SQUIBB CO
                            
                            
                                公开号:WO2006034480A2
                            
                            
                                公开(公告)日:2006-03-30
                            
                            The invention encompasses compounds of Formula (I), including pharmaceutically acceptable salts and solvates, their pharmaceutical compositions, and their uses in inhibiting β-amyloid peptide (β-AP) production.